BeiGene
id:
beigene-205-13041277
title:
BeiGene
text:
BeiGene, Ltd. is a China-based drug developer. It specializes in the development of drugs for cancer treatment. Founded in 2010 by chief executive officer John V. Oyler and Xiaodong Wang, the multinational company headquartered in Cambridge, Massachusetts has offices in North America, Europe, South America, Asia and Australia. BeiGene has a large presence in Chinese market. BeiGene has developed several pharmaceuticals, including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton's
brand slug:
wiki
category slug:
encyclopedia
description:
Global biotechnology company
original url:
https://en.wikipedia.org/wiki/BeiGene
date created:
2020-08-04T20:14:12Z
date modified:
2024-09-10T22:01:17Z
main entity:
{"identifier":"Q30260298","url":"https://www.wikidata.org/entity/Q30260298"}
image:
fields total:
13
integrity:
15